Novo Nordisk Hit by Cyberattack, Data on Clinical Trial Participants Stolen
Pharmaceutical giant Novo Nordisk confirmed a cyberattack on its internal IT systems, resulting in the theft of pseudonymized data from clinical trial participants. The company stated that direct identifiers were not exposed, mitigating the risk of participant identification, but warned of potential targeted phishing attempts against patients and healthcare partners.
Key points
- Novo Nordisk, maker of the Wegovy weight-loss drug, experienced a cyberattack affecting internal IT systems.
- Data stolen includes pseudonymized clinical trial participant information like IDs, gender, birth year, and lifestyle factors.
- The company asserts that direct patient identifiers were not compromised, preventing participant identification.
- Novo Nordisk has warned of potential targeted phishing attacks against patients and healthcare providers.
- The attack comes as the UK approves Wegovy for pill-based weight loss treatment.
Danish pharmaceutical company Novo Nordisk, known for its popular weight-loss drug Wegovy, has announced it was the victim of a cyberattack. The incident targeted a limited number of internal IT systems, leading to the compromise of pseudonymized data pertaining to participants in clinical trials.
The stolen information includes patient identifiers, details about trial participation, gender, year of birth, biomarkers, health and immunogenicity data, as well as lifestyle factors such as smoking status, alcohol consumption, and BMI. Novo Nordisk emphasized that this data is not directly linked to participants' names or other direct identifiers, and therefore, they do not believe third parties can identify individuals involved in their trials based on this breach alone. However, the company has cautioned patients to remain vigilant for any suspicious activity.
In addition to the data breach, Novo Nordisk has alerted its healthcare partners that additional personal information may have been accessed, potentially leading to targeted phishing attempts. The company has taken some affected systems offline as a precautionary measure. This cyberattack occurs concurrently with the UK's approval of Wegovy in a pill form for weight loss treatment.
Sources
The WireByte editorial team synthesises technology news from multiple primary sources, verifies the facts, and links every source. Articles are produced with AI assistance and reviewed under our editorial policy.